Dexco Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
Dexco wird ein jährliches Gewinn- und Umsatzwachstum von 32.4% bzw. 4.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 1.9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 9% betragen.
Wichtige Informationen
32.4%
Wachstumsrate der Gewinne
1.9%
EPS-Wachstumsrate
| Forestry Gewinnwachstum | 25.7% |
| Wachstumsrate der Einnahmen | 4.6% |
| Zukünftige Eigenkapitalrendite | 9.0% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 26 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Analysts Are Updating Their Dexco S.A. (BVMF:DXCO3) Estimates After Its Second-Quarter Results
Aug 10
Recent updates
Is Dexco (BVMF:DXCO3) A Risky Investment?
Oct 26Analysts Are Updating Their Dexco S.A. (BVMF:DXCO3) Estimates After Its Second-Quarter Results
Aug 10Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching
Aug 08Returns On Capital At Dexco (BVMF:DXCO3) Have Stalled
Jul 19Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts
May 13Is It Time To Consider Buying Dexco S.A. (BVMF:DXCO3)?
May 04Slowing Rates Of Return At Dexco (BVMF:DXCO3) Leave Little Room For Excitement
Apr 15Dexco's (BVMF:DXCO3) Earnings Might Not Be As Promising As They Seem
Mar 14Dexco S.A.'s (BVMF:DXCO3) Earnings Are Not Doing Enough For Some Investors
Jan 19Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet
Jan 04At R$7.43, Is Dexco S.A. (BVMF:DXCO3) Worth Looking At Closely?
Dec 04Returns Are Gaining Momentum At Dexco (BVMF:DXCO3)
Oct 08Is Dexco (BVMF:DXCO3) A Risky Investment?
Sep 13Returns At Dexco (BVMF:DXCO3) Are On The Way Up
Jun 22Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?
May 31We Like These Underlying Return On Capital Trends At Dexco (BVMF:DXCO3)
Mar 10We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt
Feb 13Dexco (BVMF:DXCO3) Might Have The Makings Of A Multi-Bagger
Dec 02We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt
Nov 13Is Now The Time To Look At Buying Dexco S.A. (BVMF:DXCO3)?
Oct 11Investors Will Want Dexco's (BVMF:DXCO3) Growth In ROCE To Persist
Aug 20We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt
Aug 05Is There Now An Opportunity In Dexco S.A. (BVMF:DXCO3)?
Jun 10There's Been No Shortage Of Growth Recently For Dexco's (BVMF:DXCO3) Returns On Capital
May 11Is Dexco (BVMF:DXCO3) Using Too Much Debt?
Apr 27Here's Why I Think Dexco (BVMF:DXCO3) Is An Interesting Stock
Mar 15Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching
Feb 24The Return Trends At Dexco (BVMF:DXCO3) Look Promising
Feb 04Here's Why We Think Dexco (BVMF:DXCO3) Is Well Worth Watching
Dec 08These 4 Measures Indicate That Dexco (BVMF:DXCO3) Is Using Debt Safely
Nov 20Dexco (BVMF:DXCO3) Is Doing The Right Things To Multiply Its Share Price
Oct 25Does Dexco (BVMF:DXCO3) Deserve A Spot On Your Watchlist?
Sep 02Duratex (BVMF:DTEX3) Has A Rock Solid Balance Sheet
Aug 18Is It Too Late To Consider Buying Duratex S.A. (BVMF:DTEX3)?
Aug 05Duratex (BVMF:DTEX3) Shareholders Will Want The ROCE Trajectory To Continue
Jul 21Does Duratex (BVMF:DTEX3) Deserve A Spot On Your Watchlist?
May 28Is Duratex (BVMF:DTEX3) Using Too Much Debt?
May 15Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 9,001 | 687 | 990 | 1,187 | 7 |
| 12/31/2025 | 8,459 | 669 | 809 | 1,095 | 9 |
| 12/31/2024 | 8,110 | 253 | 138 | 776 | 2 |
| 9/30/2024 | 8,119 | 337 | 86 | 1,482 | N/A |
| 6/30/2024 | 7,649 | 542 | -6 | 1,440 | N/A |
| 3/31/2024 | 7,607 | 602 | 39 | 1,352 | N/A |
| 12/31/2023 | 7,383 | 790 | 98 | 1,346 | N/A |
| 9/30/2023 | 7,415 | 812 | -153 | 975 | N/A |
| 6/30/2023 | 7,808 | 668 | -151 | 993 | N/A |
| 3/31/2023 | 8,068 | 680 | -456 | 726 | N/A |
| 12/31/2022 | 8,487 | 756 | -419 | 794 | N/A |
| 9/30/2022 | 8,757 | 1,128 | 15 | 1,226 | N/A |
| 6/30/2022 | 8,773 | 1,229 | 142 | 1,227 | N/A |
| 3/31/2022 | 8,533 | 1,776 | 550 | 1,505 | N/A |
| 12/31/2021 | 8,170 | 1,725 | 851 | 1,708 | N/A |
| 9/30/2021 | 7,813 | 1,446 | 863 | 1,585 | N/A |
| 6/30/2021 | 7,414 | 1,315 | 1,326 | 1,930 | N/A |
| 3/31/2021 | 6,486 | 574 | 1,289 | 1,813 | N/A |
| 12/31/2020 | 5,880 | 454 | 1,020 | 1,508 | N/A |
| 9/30/2020 | 5,472 | 437 | 1,089 | 1,536 | N/A |
| 6/30/2020 | 5,003 | 341 | 740 | 1,187 | N/A |
| 3/31/2020 | 5,101 | 434 | 578 | 1,050 | N/A |
| 12/31/2019 | 5,012 | 406 | 653 | 1,108 | N/A |
| 9/30/2019 | 4,789 | -21 | 273 | 744 | N/A |
| 6/30/2019 | 4,993 | 327 | -22 | 445 | N/A |
| 3/31/2019 | 5,016 | 425 | -4 | 437 | N/A |
| 12/31/2018 | 4,949 | 432 | -59 | 383 | N/A |
| 9/30/2018 | 4,789 | 658 | -85 | 303 | N/A |
| 6/30/2018 | 4,296 | 365 | N/A | 356 | N/A |
| 3/31/2018 | 4,045 | 223 | N/A | 340 | N/A |
| 12/31/2017 | 3,991 | 185 | N/A | 405 | N/A |
| 9/30/2017 | 3,917 | 125 | N/A | 470 | N/A |
| 6/30/2017 | 3,864 | 72 | N/A | 346 | N/A |
| 3/31/2017 | 3,960 | 47 | N/A | 540 | N/A |
| 12/31/2016 | 3,910 | 24 | N/A | 451 | N/A |
| 9/30/2016 | 3,836 | 50 | N/A | 400 | N/A |
| 6/30/2016 | 3,911 | 48 | N/A | 493 | N/A |
| 3/31/2016 | 3,863 | 85 | N/A | 443 | N/A |
| 12/31/2015 | 3,963 | 183 | N/A | 574 | N/A |
| 9/30/2015 | 4,048 | 221 | N/A | 691 | N/A |
| 6/30/2015 | 4,064 | 275 | N/A | 837 | N/A |
| 3/31/2015 | 4,056 | 296 | N/A | 739 | N/A |
| 12/31/2014 | 3,985 | 390 | N/A | 678 | N/A |
| 9/30/2014 | 3,953 | 366 | N/A | 685 | N/A |
| 6/30/2014 | 3,923 | 450 | N/A | 626 | N/A |
| 3/31/2014 | 3,937 | 526 | N/A | 709 | N/A |
| 12/31/2013 | 3,873 | 534 | N/A | 768 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: DXCO3Das prognostizierte Gewinnwachstum (32.4% pro Jahr) liegt über der Sparquote (10.4%).
Ertrag vs. Markt: DXCO3Die Erträge des Unternehmens (32.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt BR (12.5% pro Jahr).
Hohe Wachstumserträge: DXCO3Es wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: DXCO3Die Einnahmen des Unternehmens (4.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt BR (7.4% pro Jahr).
Hohe Wachstumseinnahmen: DXCO3Die Einnahmen des Unternehmens (4.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: DXCO3Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (9%).